Assertio Holdings Faces Securities Law Investigation

Multiple law firms are investigating Assertio Holdings, Inc. (ASRT) for potential violations of federal securities laws related to its reliance on Indocin products and the FDA's approval of a generic version of Indocin Suppositories. The investigation stems from significant drops in the company's stock price, failure to meet consensus estimates for financial results, and the departure of its CEO. The law firms are encouraging investors to seek legal advice and consider joining the lawsuits.